Ivosidenib (IVO) prior to hematopoietic cell transplant for patients with IDH1-mutant relapsed or refractory acute myeloid leukemia (R/R AML) Meeting Abstract
| Authors: | Dinardo, C. D.; Stein, E.; Pigneux, A.; Altman, J. K.; Collins, R.; Erba, H. P.; Watts, J. M.; Uy, G. L.; Kapsalis, S. M.; Liu, H.; Winkler, T.; Roboz, G. J.; de Botton, S. |
| Abstract Title: | Ivosidenib (IVO) prior to hematopoietic cell transplant for patients with IDH1-mutant relapsed or refractory acute myeloid leukemia (R/R AML) |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Start Page: | 404s |
| Language: | English |
| ACCESSION: | WOS:000560368303183 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.7521 |
| Notes: | Meeting Abstract: 7521 -- Source: Wos |
